Salahop, Naomie .
HRN: 11-41-36 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/13/2023
CEFUROXIME 1.5GM (VIAL)
01/13/2023
01/13/2023
IV
1.5
Oncall To OR
Nka
Waiting Final Action
01/13/2023
CEFUROXIME 1.5GM (VIAL)
01/13/2023
01/20/2023
IV
1.5g
Q8
LTCS
Waiting Final Action
01/14/2023
CEFUROXIME 500MG (TAB)
01/14/2023
01/20/2023
ORAL
500
BID
LTCS
Waiting Final Action